vs
JOHNSON OUTDOORS INC(JOUT)与Orthofix Medical Inc.(OFIX)财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是JOHNSON OUTDOORS INC的1.6倍($219.9M vs $140.9M),Orthofix Medical Inc.净利率更高(-1.0% vs -2.3%,领先1.3%),JOHNSON OUTDOORS INC同比增速更快(30.9% vs 2.0%),Orthofix Medical Inc.自由现金流更多($16.8M vs $-42.7M),过去两年Orthofix Medical Inc.的营收复合增速更高(8.0% vs -10.5%)
强生户外公司(Johnson Outdoors)主营水上载具、潜水装备、露营用具、户外服饰等户外休闲用品的研发生产,业务网点遍布全球24个地区,现有员工约1400人,年销售额超3.15亿美元,自1999年起由海伦·约翰逊-莱波尔德执掌公司。
Orthofix医疗是全球知名骨科医疗器械企业,专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品,服务全球多地的骨科医师与医疗机构,致力于提升肌肉骨骼疾病患者的诊疗效果。
JOUT vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.6倍
$140.9M
营收增速更快
JOUT
高出28.9%
2.0%
净利率更高
OFIX
高出1.3%
-2.3%
自由现金流更多
OFIX
多$59.5M
$-42.7M
两年增速更快
OFIX
近两年复合增速
-10.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $140.9M | $219.9M |
| 净利润 | $-3.3M | $-2.2M |
| 毛利率 | 36.6% | 71.1% |
| 营业利润率 | -2.1% | 0.2% |
| 净利率 | -2.3% | -1.0% |
| 营收同比 | 30.9% | 2.0% |
| 净利润同比 | 78.4% | 92.4% |
| 每股收益(稀释后) | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
JOUT
OFIX
| Q1 26 | $140.9M | — | ||
| Q4 25 | $135.8M | $219.9M | ||
| Q3 25 | — | $205.6M | ||
| Q2 25 | $180.7M | $203.1M | ||
| Q1 25 | $168.3M | $193.6M | ||
| Q4 24 | $107.6M | $215.7M | ||
| Q3 24 | $105.9M | $196.6M | ||
| Q2 24 | $172.5M | $198.6M |
净利润
JOUT
OFIX
| Q1 26 | $-3.3M | — | ||
| Q4 25 | $-29.1M | $-2.2M | ||
| Q3 25 | — | $-22.8M | ||
| Q2 25 | $7.7M | $-14.1M | ||
| Q1 25 | $2.3M | $-53.1M | ||
| Q4 24 | $-15.3M | $-29.1M | ||
| Q3 24 | $-34.3M | $-27.4M | ||
| Q2 24 | $1.6M | $-33.4M |
毛利率
JOUT
OFIX
| Q1 26 | 36.6% | — | ||
| Q4 25 | 36.2% | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | 37.6% | 68.7% | ||
| Q1 25 | 35.0% | 62.8% | ||
| Q4 24 | 29.9% | 69.0% | ||
| Q3 24 | 23.5% | 68.7% | ||
| Q2 24 | 35.8% | 67.8% |
营业利润率
JOUT
OFIX
| Q1 26 | -2.1% | — | ||
| Q4 25 | -6.0% | 0.2% | ||
| Q3 25 | — | -8.3% | ||
| Q2 25 | 4.1% | -7.9% | ||
| Q1 25 | 2.9% | -25.2% | ||
| Q4 24 | -18.8% | -5.3% | ||
| Q3 24 | -40.4% | -9.6% | ||
| Q2 24 | -0.3% | -12.5% |
净利率
JOUT
OFIX
| Q1 26 | -2.3% | — | ||
| Q4 25 | -21.4% | -1.0% | ||
| Q3 25 | — | -11.1% | ||
| Q2 25 | 4.3% | -6.9% | ||
| Q1 25 | 1.4% | -27.4% | ||
| Q4 24 | -14.2% | -13.5% | ||
| Q3 24 | -32.4% | -13.9% | ||
| Q2 24 | 0.9% | -16.8% |
每股收益(稀释后)
JOUT
OFIX
| Q1 26 | — | — | ||
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.57 | ||
| Q2 25 | — | $-0.36 | ||
| Q1 25 | — | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | — | $-0.71 | ||
| Q2 24 | — | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $130.7M | $82.0M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $413.5M | $450.0M |
| 总资产 | $600.1M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势,按日历期对齐
现金及短期投资
JOUT
OFIX
| Q1 26 | $130.7M | — | ||
| Q4 25 | $176.4M | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | $161.0M | $65.6M | ||
| Q1 25 | $94.0M | $58.0M | ||
| Q4 24 | $101.6M | $83.2M | ||
| Q3 24 | $162.0M | $30.1M | ||
| Q2 24 | $148.4M | $26.4M |
总债务
JOUT
OFIX
| Q1 26 | $0 | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | $0 | $157.0M | ||
| Q1 25 | $0 | $156.9M | ||
| Q4 24 | $0 | $157.0M | ||
| Q3 24 | $0 | $118.5M | ||
| Q2 24 | $0 | $118.0M |
股东权益
JOUT
OFIX
| Q1 26 | $413.5M | — | ||
| Q4 25 | $418.4M | $450.0M | ||
| Q3 25 | — | $442.5M | ||
| Q2 25 | $450.5M | $458.3M | ||
| Q1 25 | $441.1M | $458.3M | ||
| Q4 24 | $440.3M | $503.1M | ||
| Q3 24 | $463.4M | $525.9M | ||
| Q2 24 | $498.7M | $546.0M |
总资产
JOUT
OFIX
| Q1 26 | $600.1M | — | ||
| Q4 25 | $604.1M | $850.6M | ||
| Q3 25 | — | $832.6M | ||
| Q2 25 | $634.5M | $837.2M | ||
| Q1 25 | $624.5M | $823.1M | ||
| Q4 24 | $612.9M | $893.3M | ||
| Q3 24 | $635.2M | $867.9M | ||
| Q2 24 | $679.8M | $882.0M |
负债/权益比
JOUT
OFIX
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | 0.00× | 0.34× | ||
| Q1 25 | 0.00× | 0.34× | ||
| Q4 24 | 0.00× | 0.31× | ||
| Q3 24 | 0.00× | 0.23× | ||
| Q2 24 | 0.00× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-38.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-42.7M | $16.8M |
| 自由现金流率自由现金流/营收 | -30.3% | 7.6% |
| 资本支出强度资本支出/营收 | 3.0% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $38.5M | $-1.3M |
8季度趋势,按日历期对齐
经营现金流
JOUT
OFIX
| Q1 26 | $-38.4M | — | ||
| Q4 25 | $23.4M | $27.7M | ||
| Q3 25 | — | $12.4M | ||
| Q2 25 | $71.4M | $11.6M | ||
| Q1 25 | $-1.7M | $-18.4M | ||
| Q4 24 | $-36.9M | $23.7M | ||
| Q3 24 | $19.1M | $11.7M | ||
| Q2 24 | $73.7M | $9.0M |
自由现金流
JOUT
OFIX
| Q1 26 | $-42.7M | — | ||
| Q4 25 | $19.2M | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | $66.9M | $4.5M | ||
| Q1 25 | $-5.0M | $-25.1M | ||
| Q4 24 | $-41.0M | $15.2M | ||
| Q3 24 | $13.5M | $6.3M | ||
| Q2 24 | $67.4M | $-360.0K |
自由现金流率
JOUT
OFIX
| Q1 26 | -30.3% | — | ||
| Q4 25 | 14.2% | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | 37.0% | 2.2% | ||
| Q1 25 | -2.9% | -13.0% | ||
| Q4 24 | -38.1% | 7.0% | ||
| Q3 24 | 12.8% | 3.2% | ||
| Q2 24 | 39.1% | -0.2% |
资本支出强度
JOUT
OFIX
| Q1 26 | 3.0% | — | ||
| Q4 25 | 3.1% | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | 2.5% | 3.5% | ||
| Q1 25 | 2.0% | 3.5% | ||
| Q4 24 | 3.8% | 4.0% | ||
| Q3 24 | 5.3% | 2.7% | ||
| Q2 24 | 3.6% | 4.7% |
现金转化率
JOUT
OFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 9.22× | — | ||
| Q1 25 | -0.72× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 45.41× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JOUT
| Fishing Segment | $112.1M | 80% |
| Diving Segment | $18.0M | 13% |
| Camping Watercraft Recreation Segment | $10.6M | 8% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |